2025
book
OpenAlex
Herbert P Wiedemann
Geboren 1932, Habilitation in München; 1965-68 Universitätsprofessor in Berlin; 1969-97 in Köln; Richter am Oberlandesgericht Düsseldorf a. D.; emeritierter Professor der Rechtswissenschaftlichen Fakultät der Universität zu Köln.
Accès ouvert
2024
article
OpenAlex
Neil R. Aggarwal, Jacquie Nordwall, Dominique L. Braun, Lucy K. Chung et autres
BACKGROUND: Persistent mortality in adults hospitalized due to acute COVID-19 justifies pursuit of disease mechanisms and potential therapies. The aim was to evaluate which virus and host response factors were associated with mortality risk among participants in Therapeutics for Inpatients with COVID-19 …
us, ch, Nigéria, es, dk, gb, gr
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Tomas Østergaard Jensen, Greg Grandits, Mamta K. Jain, Thomas A. Murray et autres
BACKGROUND: Neutralizing monoclonal antibodies (nmAbs) failed to show clear benefit for hospitalized patients with coronavirus disease 2019 (COVID-19). Dynamics of virologic and immunologic biomarkers remain poorly understood. METHODS: Participants enrolled in the Therapeutics for Inpatients with COVID-19 trials were randomized to nmAb …
dk, us, gb, gr, Ouganda, au
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Eleftherios E Mylonakis, Barnaby Edward Young, David M. Vock, Lianne K. Siegel et autres
BACKGROUND: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection. OBJECTIVE: To investigate if ensovibep, in addition to remdesivir and other standard care, improves clinical outcomes among patients hospitalized …
us, gr, sg, Ouganda, gb, Nigéria, ch, dk, au, es, pl
(code pays fourni par la source)
2022
article
OpenAlex
Herbert P Wiedemann
Accès ouvert
2021
article
OpenAlex
John G. Weg, François Lemaire, Edward N. Pattishall, Antoni Artigas Raventós et autres
BACKGROUND: Patients with acute respiratory distress syndrome (ARDS) have a deficiency of surfactant. Surfactant replacement improves physiologic function in such patients, and preliminary data suggest that it may improve survival. METHODS: We conducted a prospective, multicenter, double-blind, randomized, placebo-controlled trial involving 725 …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Paul C Cremer, Antonio Abbate, Kristin M. Hudock, Carla Sue McWilliams et autres
us
(code pays fourni par la source)
2020
book-chapter
OpenAlex
Herbert P Wiedemann
2019
article
OpenAlex
Herbert P Wiedemann
de
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Matthew W. Semler, Arthur P. Wheeler, Bruce Thompson, Gordon R. Bernard et autres
OBJECTIVES: In acute respiratory distress syndrome, conservative fluid management increases ventilator-free days without affecting mortality. Response to fluid management may differ based on patients' initial central venous pressure. We hypothesized that initial central venous pressure would modify the effect of fluid management …
us, il
(code pays fourni par la source)
2015
book-chapter
OpenAlex
Frank Cosentino, John D. Lockrem, James K. Stoller, Herbert P Wiedemann
us
(code pays fourni par la source)
2015
book-chapter
OpenAlex
Herbert P Wiedemann